These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3067951)

  • 1. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.
    Small M; MacRury S; Boal A; Paterson KR; MacCuish AC
    Diabetes Res; 1988 Jun; 8(2):85-9. PubMed ID: 3067951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of unstable diabetes mellitus in children and adolescents using insulin administered by a semi-automated syringe, NovoPen].
    Necić S; Nikezić M; Sajić S; Radmanović S
    Srp Arh Celok Lek; 1989; 117(7-8):453-8. PubMed ID: 2688138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patient preferences.
    Fisken RA; Goulbourn J
    Diabetes Res; 1989 Aug; 11(4):195-7. PubMed ID: 2696619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
    Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
    Roos AN; Meinders AE
    Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
    Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
    Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic control and acceptance of a regimen of multiple injections using an insulin (novopen) injector in a group of juvenile diabetics].
    Ugart Líbano R; Ruiz de Larrea Pérez C; Edroso Albaina L
    An Esp Pediatr; 1990 Apr; 32(4):299-302. PubMed ID: 2368991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
    Soliman AT; Omar M; Rizk MM; El Awwa A; AlGhobashy FM
    J Trop Pediatr; 2006 Aug; 52(4):276-81. PubMed ID: 16410276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basal bolus therapy in adolescent diabetic patients].
    Steinemann MA; Zuppinger K
    Ther Umsch; 1990 Jan; 47(1):22-9. PubMed ID: 2408179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A within patient cross over trial of 4 insulin regimens in antibody-negative, C-peptide negative patients.
    Oswald GA; Yudkin JS
    Diabetes Res; 1987 Feb; 4(2):85-9. PubMed ID: 3555956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with NovoPen II and insulin Protaphane HM Penfill.
    Kølendorf K; Beck-Nielsen H; Oxenbøll B
    Postgrad Med J; 1988; 64 Suppl 3():14-6; discussion 21. PubMed ID: 3074294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixtard 30 HM Penfill insulin treatment in selected young insulin-dependent diabetes mellitus patients. Romanian Young Diabetics Study Team (RYDST).
    Rom J Intern Med; 1997; 35(1-4):99-113. PubMed ID: 9562659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comparison with human insulin 30/70.
    Schernthaner G; Kopp HP; Ristic S; Muzyka B; Peter L; Mitteregger G
    Horm Metab Res; 2004 Mar; 36(3):188-93. PubMed ID: 15057674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two intensified conventional insulin regimens with three and four daily injections.
    Faglia E; Favales F; Brivio M; Calia P; Quarantiello A
    Diabete Metab; 1993; 19(6):575-81. PubMed ID: 8026609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with functional insulin therapy: metabolic follow up and patient cooperation].
    Fövényi J; Szövérffy G; Thaisz E; Lehotkai L
    Orv Hetil; 1991 Sep; 132(36):1963-7. PubMed ID: 1923467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insuject-X for children. A clinical trial of the NPH insulin pen].
    Rix M; Voght H; Nielsen K; Jakobsen G; Holsteen V
    Ugeskr Laeger; 1990 Apr; 152(15):1086-9. PubMed ID: 2184557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.